Inventor
OR YAT SUN
US336 patents
⚠️ This page may combine multiple inventors who share the name “OR YAT SUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ENANTA PHARM INC
30 patentsUS7176208B2Feb 13, 2007
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
ENANTA PHARM INC111 citations99
US7635683B2Dec 22, 2009
Quinoxalinyl tripeptide hepatitis C virus inhibitors
ENANTA PHARM INC75 citations98
US9957281B2May 1, 2018
Benzodiazepine derivatives as RSV inhibitors
ENANTA PHARM INC32 citations97
US6878691B2Apr 12, 2005
6-11 bicyclic ketolide derivatives
ENANTA PHARM INC73 citations97
US6680299B2Jan 20, 2004
4'-substituted leucomycins
ENANTA PHARM INC71 citations97
US7125845B2Oct 24, 2006
Aza-peptide macrocyclic hepatitis C serine protease inhibitors
ENANTA PHARM INC57 citations95
US10865215B2Dec 15, 2020
Benzodiazepine derivatives as RSV inhibitors
ENANTA PHARM INC16 citations94
US10683279B2Jun 16, 2020
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC13 citations94
US10538532B2Jan 21, 2020
Hepatitis B antiviral agents
ENANTA PHARM INC17 citations94
US10428070B2Oct 1, 2019
Hepatitis B antiviral agents
ENANTA PHARM INC24 citations94
US10398706B2Sep 3, 2019
Heteroaryldiazepine derivatives as RSV inhibitors
ENANTA PHARM INC26 citations94
US10358441B2Jul 23, 2019
Processes for the preparation of benzodiazepine derivatives
ENANTA PHARM INC27 citations94
US10189846B2Jan 29, 2019
Hepatitis B antiviral agents
ENANTA PHARM INC25 citations94
US10179131B2Jan 15, 2019
Hepatitis B antiviral agents
ENANTA PHARM INC27 citations94
US10179792B2Jan 15, 2019
Hepatitis B antiviral agents
ENANTA PHARM INC17 citations94
US10034893B2Jul 31, 2018
5, 6-D2 uridine nucleoside/tide derivatives
ENANTA PHARM INC34 citations94
US8846638B2Sep 30, 2014
Macrocyclic nucleoside phosphoramidate derivatives
ENANTA PHARM INC34 citations94
US7582605B2Sep 1, 2009
Phosphorus-containing hepatitis C serine protease inhibitors
ENANTA PHARM INC59 citations94
US7368452B2May 6, 2008
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
ENANTA PHARM INC35 citations94
US7687459B2Mar 30, 2010
Arylalkoxyl hepatitis C virus protease inhibitors
ENANTA PHARM INC26 citations93
US7189704B2Mar 13, 2007
6-11 bicyclic ketolide derivatives
ENANTA PHARM INC15 citations93
US7022679B2Apr 4, 2006
Processes for the preparation of 6-11 bicyclic erythromycin derivatives
ENANTA PHARM INC21 citations93
US6764998B1Jul 20, 2004
6,11-4C-bicyclic 9a-azalide derivatives
ENANTA PHARM INC39 citations93
US7605126B2Oct 20, 2009
Acylaminoheteroaryl hepatitis C virus protease inhibitors
ENANTA PHARM INC38 citations92
US7566719B2Jul 28, 2009
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
ENANTA PHARM INC20 citations92
US7273853B2Sep 25, 2007
6-11 bicyclic ketolide derivatives
ENANTA PHARM INC35 citations92
US7129221B2Oct 31, 2006
6,11-bicyclic erythromycin derivatives
ENANTA PHARM INC25 citations92
US7012065B2Mar 14, 2006
Cyclosporins for the treatment of immune disorders
ENANTA PHARM INC41 citations92
US6784156B2Aug 31, 2004
Cyclosporins for the treatment of respiratory diseases
ENANTA PHARM INC39 citations92
US6645941B1Nov 11, 2003
6,11-3C-bicyclic 9a-azalide derivatives
ENANTA PHARM INC41 citations92
ABBOTT LAB
17 patentsUS5866549AFeb 2, 1999
6-O-substituted ketolides having antibacterial activity
ABBOTT LAB176 citations99
US5922683AJul 13, 1999
Multicyclic erythromycin derivatives
ABBOTT LAB101 citations97
US5457111AOct 10, 1995
Macrocyclic immunomodulators
ABBOTT LAB160 citations97
US6124269ASep 26, 2000
2-Halo-6-O-substituted ketolide derivatives
ABBOTT LAB97 citations96
US6075133AJun 13, 2000
6-O-substituted antibacterial erythromycin ketolides and methods of making
ABBOTT LAB43 citations96
US5672605ASep 30, 1997
Macrolide immunomodulators
ABBOTT LAB69 citations96
US5583139ADec 10, 1996
Marcolide immunomodulators
ABBOTT LAB65 citations96
US6054435AApr 25, 2000
6-O-substituted macrolides having antibacterial activity
ABBOTT LAB74 citations95
US6420535B1Jul 16, 2002
6-O-carbamate ketolide derivatives
ABBOTT LAB35 citations93
US6034069AMar 7, 2000
3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
ABBOTT LAB28 citations93
US5780605AJul 14, 1998
6,9-bridged erythromycin derivatives
ABBOTT LAB37 citations93
US5604234AFeb 18, 1997
Substituted thiol macrolactam immunomodulators
ABBOTT LAB27 citations93
US5563172AOct 8, 1996
Macrocyclic amide and urea immunomodulators
ABBOTT LAB25 citations93
US5561137AOct 1, 1996
Thio-heterocyclic macrolactam immunomodulators
ABBOTT LAB26 citations93
US5534632AJul 9, 1996
Macrocyclic carbamate immunomodulators
ABBOTT LAB24 citations93
US6946446B2Sep 20, 2005
Anti-infective agents useful against multidrug-resistant strains of bacteria
ABBOTT LAB21 citations92
US6355620B1Mar 12, 2002
C-2 modified erythromycin derivatives
ABBOTT LAB38 citations92
QIU YAO-LING
1 patentWANG GUOQIANG
1 patentOR YAT SUN
1 patentShowing the top 50 of 336 patents by PatentIndex Score.